Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Juvenile Myelomonocytic Leukemia
|
26 | 0.611 | 0.560 | 1 | 114716126 | missense variant | C/A;G;T | snv | 8.0E-06 | 0.810 | 1.000 | 1 | 2007 | 2014 | |||||
Leukemia, Myelocytic, Acute
|
247 | 0.611 | 0.560 | 1 | 114716126 | missense variant | C/A;G;T | snv | 8.0E-06 | 0.740 | 1.000 | 4 | 1987 | 2017 | |||||
melanoma
|
352 | 0.611 | 0.560 | 1 | 114716126 | missense variant | C/A;G;T | snv | 8.0E-06 | 0.740 | 1.000 | 4 | 1989 | 2016 | |||||
Cutaneous Melanoma
|
58 | 0.611 | 0.560 | 1 | 114716126 | missense variant | C/A;G;T | snv | 8.0E-06 | 0.710 | 1.000 | 1 | 2013 | 2016 | |||||
Neoplasms
|
1571 | 0.611 | 0.560 | 1 | 114716126 | missense variant | C/A;G;T | snv | 8.0E-06 | 0.100 | 1.000 | 10 | 2010 | 2020 | |||||
Chronic myeloproliferative disorder
|
44 | 0.611 | 0.560 | 1 | 114716126 | missense variant | C/A;G;T | snv | 8.0E-06 | 0.040 | 1.000 | 4 | 2011 | 2017 | |||||
Myeloproliferative disease
|
35 | 0.611 | 0.560 | 1 | 114716126 | missense variant | C/A;G;T | snv | 8.0E-06 | 0.030 | 1.000 | 3 | 2011 | 2017 | |||||
Carcinogenesis
|
355 | 0.611 | 0.560 | 1 | 114716126 | missense variant | C/A;G;T | snv | 8.0E-06 | 0.020 | 1.000 | 2 | 2015 | 2015 | |||||
leukemia
|
138 | 0.611 | 0.560 | 1 | 114716126 | missense variant | C/A;G;T | snv | 8.0E-06 | 0.020 | 1.000 | 2 | 2011 | 2014 | |||||
Leukemogenesis
|
25 | 0.611 | 0.560 | 1 | 114716126 | missense variant | C/A;G;T | snv | 8.0E-06 | 0.020 | 1.000 | 2 | 2013 | 2019 | |||||
Acute Undifferentiated Leukemia
|
1 | 0.611 | 0.560 | 1 | 114716126 | missense variant | C/A;G;T | snv | 8.0E-06 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
Adenocarcinoma
|
167 | 0.611 | 0.560 | 1 | 114716126 | missense variant | C/A;G;T | snv | 8.0E-06 | 0.010 | 1.000 | 1 | 2020 | 2020 | |||||
Adenocarcinoma, intestinal type
|
2 | 0.611 | 0.560 | 1 | 114716126 | missense variant | C/A;G;T | snv | 8.0E-06 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Adult Diffuse Large B-Cell Lymphoma
|
42 | 0.611 | 0.560 | 1 | 114716126 | missense variant | C/A;G;T | snv | 8.0E-06 | 0.010 | 1.000 | 1 | 1997 | 1997 | |||||
Adult Lymphoma
|
66 | 0.611 | 0.560 | 1 | 114716126 | missense variant | C/A;G;T | snv | 8.0E-06 | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||
Adult Pilocytic Astrocytoma
|
10 | 0.611 | 0.560 | 1 | 114716126 | missense variant | C/A;G;T | snv | 8.0E-06 | 0.010 | 1.000 | 1 | 2007 | 2007 | |||||
B-CELL MALIGNANCY, LOW-GRADE
|
19 | 0.611 | 0.560 | 1 | 114716126 | missense variant | C/A;G;T | snv | 8.0E-06 | 0.010 | 1.000 | 1 | 1997 | 1997 | |||||
Brain Neoplasms
|
85 | 0.611 | 0.560 | 1 | 114716126 | missense variant | C/A;G;T | snv | 8.0E-06 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Carcinoma of lung
|
995 | 0.611 | 0.560 | 1 | 114716126 | missense variant | C/A;G;T | snv | 8.0E-06 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Childhood Leukemia
|
140 | 0.611 | 0.560 | 1 | 114716126 | missense variant | C/A;G;T | snv | 8.0E-06 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
Childhood Lymphoma
|
66 | 0.611 | 0.560 | 1 | 114716126 | missense variant | C/A;G;T | snv | 8.0E-06 | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||
Childhood Pilocytic Astrocytoma
|
10 | 0.611 | 0.560 | 1 | 114716126 | missense variant | C/A;G;T | snv | 8.0E-06 | 0.010 | 1.000 | 1 | 2007 | 2007 | |||||
Chronic Lymphocytic Leukemia
|
125 | 0.611 | 0.560 | 1 | 114716126 | missense variant | C/A;G;T | snv | 8.0E-06 | 0.010 | 1.000 | 1 | 1997 | 1997 | |||||
Developmental Disabilities
|
18 | 0.611 | 0.560 | 1 | 114716126 | missense variant | C/A;G;T | snv | 8.0E-06 | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||
Diffuse Large B-Cell Lymphoma
|
109 | 0.611 | 0.560 | 1 | 114716126 | missense variant | C/A;G;T | snv | 8.0E-06 | 0.010 | 1.000 | 1 | 1997 | 1997 |